Drugs / Roneparstat
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01764880 | Nov 2012 → Nov 2016 | plasma cell myeloma | Sigma Tau Research Switzerland SA | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Roneparstat | “SST0001 (Roneparstat)” NCT01764880 ↗ |
| Known as | SST0001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01764880 ↗ |
| Modality | Other / unclassified | “SST0001 is a polymer with a heparin-like structure.” NCT01764880 ↗ |
| Route | Subcutaneous | “SST0001 given subcutaneously (sc)” NCT01764880 ↗ |